Researcher working with AI to change breast cancer care forever

Michael Walter | | Health Exec | Precision Medicine

Regina Barzilay, PhD, a professor at the Massachusetts Institute of Technology, has been working closely with AI technologies to improve breast cancer care ever since she was diagnosed with the disease in 2014.

According to a new feature story from The New York Times, the experience showed her just how much “uncertainty” breast cancer patients go through when receiving treatment. It inspired her to learn more and work to make a difference.

Using A.I. to Transform Breast Cancer Care

Through her research, Barzilay has trained algorithms to scan mammograms and produce detailed evaluations that could help reduce radiologist workload and improve patient care. Prior Radiology Business coverage of her work can be read here and here.

“Machines work more effectively than human eyes,” Barzilay said, as quoted by the New York Times. “They can register subtle changes in tissue—influenced by genetics, hormones, lactation, weight changes—that we cannot see.”

To read the full story, click the link below.  

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

AI in Healthcare
4 ways HHS plans to help shape a national strategy for healthcare AI

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.

Cardiovascular Business
FDA announces recall after Philips heart monitor software failed to send alerts—multiple deaths reported

Philips is recalling the software associated with its Mobile Cardiac Outpatient Telemetry devices after certain high-risk ECG events were never routed to trained cardiology technicians as intended. The issue, which lasted for two years, has been linked to more than 100 injuries. 

Cardiovascular Business
Why electrophysiologists needed a champion in Washington

Heart Rhythm Society President Kenneth A. Ellenbogen, MD, detailed a new advocacy group focused on improving EP reimbursements, patient care and access. “If you’re not at the table, you’re on the menu," he said.